AUG 14, 2026 · PHASE 4 TRIAL
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
ClinicalTrials.gov
This is a completed Phase 4 registry record with no posted results; the study design and primary endpoint are stated but outcomes remain unreported.
Reported
Planned enrollment81
Primary outcome measurePulmonary Capillary Wedge Pressure (PCWP),…
Study phasePhase 4